Mycocycle, Inc., a leader in using mycoremediation to process toxins out of waste and a member of the Roofing Technology Think Tank (RT3), today announced the launch of its StartEngine equity crowdfunding campaign. The StartEngine platform gives the public the opportunity to invest in startup companies in return for equity in the company.
"We are thrilled to be participating in the new world of equity crowdfunding,” said Joanne Rodriguez, Mycocycle founder and CEO, as well as a roofing industry veteran. “Mycocycle is committed to using the science of mushrooms to divert roofing waste from landfills. With only 15 percent of landfill space left, we must work to find a better solution. Together, we can change how we view waste: as a resource, not a burden."
Mycocycle uses mushrooms to remove toxins from waste and convert it into reusable resources. The company is an early-stage, pre-revenue startup that has lab-based proof of concept on multiple treatment methodologies. The patent-pending process accelerates and emulates the process of breaking down materials in nature, but in an enclosed and controlled environment. The company is raising funding to support the simultaneous scale up and derisk of its technology.
“We encourage anyone interested in helping the environment to consider investing,” Rodriguez stated. “With the help of crowdfunding, we can help launch the waste management industry into the future.”
Learn more about the company’s mission, goals and growth plan by visiting www.startengine.com/mycocycle.
About Mycocycle
Mycocycle, Inc. was founded in October 2018. It is a woman-owned, early stage cleantech company using mycoremediation to process toxins out of waste. Mycocycle was recognized as a Finalist in FastCompany's "2020 World Changing Ideas" Awards issue, a presenter for NREL's 2020 Industry Growth Forum, a 2020 Innovation selection in the EPA's Innovation and America Recycle's Fair, and the winner of the Cleantech Open National 2020 Resiliency Challenge. For more information visit www.mycocycle.com.
Comments
Leave a Reply
Have an account? Login to leave a comment!
Sign In